A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
Conditions
Well Differentiated Liposarcoma · Dedifferentiated Liposarcoma · Liposarcoma · Myxoid Liposarcoma · Round Cell Liposarcoma · Myxoid Pleomorphic Liposarcoma · Pleomorphic Liposarcoma · Unresectable Liposarcoma · Unresectable Dedifferentiated Liposarcoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
Contact: Study coordinator (Olayode Babatunde, MD) · zzPDL_MED_Sarcoma_Clinical_Trials@mskcc.org · 646-888-4363Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities), Commack, New York, United States
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Contact: Study coordinator (Olayode Babatunde, MD) · zzPDL_MED_Sarcoma_Clinical_Trials@mskcc.org · 646-888-4363Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
Study leads
Olayode Babatunde, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center